{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:15:02Z","timestamp":1787224502069,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Integrative Medicine Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.imr.2021.100773","type":"journal-article","created":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T17:22:01Z","timestamp":1629652921000},"page":"100773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Safety and efficacy of dietary supplement (gintonin-enriched fraction from ginseng) in subjective memory impairment: A randomized placebo-controlled trial"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6090-7921","authenticated-orcid":false,"given":"Woo-Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6781-7782","authenticated-orcid":false,"given":"Yong-Won","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4512-3210","authenticated-orcid":false,"given":"Hyeyeon","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5861-2876","authenticated-orcid":false,"given":"Hye-Rim","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2487-8064","authenticated-orcid":false,"given":"Won-Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1918-2206","authenticated-orcid":false,"given":"Seok-Won","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0277-6326","authenticated-orcid":false,"given":"Manho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9697-4763","authenticated-orcid":false,"given":"Seung-Yeol","family":"Nah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imr.2021.100773_bib0001","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"10113","key":"10.1016\/j.imr.2021.100773_bib0002","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet North Am Ed"},{"issue":"3","key":"10.1016\/j.imr.2021.100773_bib0003","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"3","key":"10.1016\/j.imr.2021.100773_bib0004","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jalz.2009.01.028","article-title":"Early identification and treatment of Alzheimer\u2019s disease: social and fiscal outcomes","volume":"5","author":"Weimer","year":"2009","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"1","key":"10.1016\/j.imr.2021.100773_bib0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jalz.2012.09.017","article-title":"AD dementia risk in late MCI, in early MCI, and in subjective memory impairment","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"4","key":"10.1016\/j.imr.2021.100773_bib0006","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/archgenpsychiatry.2010.30","article-title":"Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment","volume":"67","author":"Jessen","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"10.1016\/j.imr.2021.100773_bib0007","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S1474-4422(07)70109-6","article-title":"Effect of rivastigmine on delay to diagnosis of Alzheimer\u2019s disease from mild cognitive impairment: the InDDEx study","volume":"6","author":"Feldman","year":"2007","journal-title":"Lancet Neurol"},{"issue":"18","key":"10.1016\/j.imr.2021.100773_bib0008","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/01.wnl.0000344650.95823.03","article-title":"Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial","volume":"72","author":"Doody","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.imr.2021.100773_bib0009","article-title":"Donepezil for mild cognitive impairment","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.imr.2021.100773_bib0010","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.neurobiolaging.2014.03.033","article-title":"Dietary and lifestyle guidelines for the prevention of Alzheimer's disease","volume":"35","author":"Barnard","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.imr.2021.100773_bib0011","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0091-3057(03)00126-6","article-title":"Ginseng: potential for the enhancement of cognitive performance and mood","volume":"75","author":"Kennedy","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.imr.2021.100773_bib0012","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/WAD.0b013e31816c92e6","article-title":"Panax ginseng enhances cognitive performance in Alzheimer disease","volume":"22","author":"Lee","year":"2008","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"12","key":"10.1016\/j.imr.2021.100773_bib0013","article-title":"Ginseng for cognition","author":"Geng","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.imr.2021.100773_bib0014","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/2045-080X.183030","article-title":"A review of Panax ginseng as an herbal medicine","volume":"7","author":"Nuri","year":"2016","journal-title":"Arch Pharm Pract"},{"issue":"2","key":"10.1016\/j.imr.2021.100773_bib0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/S10059-012-2216-z","article-title":"Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity","volume":"33","author":"Hwang","year":"2012","journal-title":"Mol Cells"},{"key":"10.1016\/j.imr.2021.100773_bib0016","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fphar.2015.00245","article-title":"Ginseng pharmacology: a new paradigm based on gintonin-lysophosphatidic acid receptor interactions","volume":"6","author":"Choi","year":"2015","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.imr.2021.100773_bib0017","doi-asserted-by":"crossref","first-page":"796","DOI":"10.14348\/molcells.2015.0116","article-title":"Oral administration of gintonin attenuates cholinergic impairments by scopolamine, amyloid-\u03b2 protein, and mouse model of Alzheimer's disease","volume":"38","author":"Kim","year":"2015","journal-title":"Mol Cells"},{"issue":"1","key":"10.1016\/j.imr.2021.100773_bib0018","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/JAD-2012-120439","article-title":"Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing","volume":"31","author":"Hwang","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.imr.2021.100773_bib0019","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1152\/jn.00667.2014","article-title":"Synaptic enhancement induced by gintonin via lysophosphatidic acid receptor activation in central synapses","volume":"113","author":"Park","year":"2015","journal-title":"J Neurophysiol"},{"issue":"6","key":"10.1016\/j.imr.2021.100773_bib0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10059-012-0254-4","article-title":"Gintonin, a ginseng-derived novel ingredient, evokes long-term potentiation through N-methyl-D-aspartic acid receptor activation: involvement of LPA receptors","volume":"34","author":"Shin","year":"2012","journal-title":"Mol Cells"},{"issue":"1","key":"10.1016\/j.imr.2021.100773_bib0021","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jgr.2015.05.001","article-title":"Hippocampus-dependent cognitive enhancement induced by systemic gintonin administration","volume":"40","author":"Kim","year":"2016","journal-title":"J Ginseng Res"},{"issue":"1","key":"10.1016\/j.imr.2021.100773_bib0022","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/WAD.0000000000000213","article-title":"Gintonin administration is safe and potentially beneficial in cognitively impaired elderly","volume":"32","author":"Moon","year":"2018","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"1","key":"10.1016\/j.imr.2021.100773_bib0023","first-page":"1","article-title":"Effect of desalted Salicornia europaea L. ethanol extract (PM-EE) on the subjects complaining memory dysfunction without dementia: a 12 week, randomized, double-blind, placebo-controlled clinical trial","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.imr.2021.100773_bib0024","first-page":"300","article-title":"A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients","volume":"15","author":"Kang","year":"1997","journal-title":"J Korean Neurol Assoc"},{"issue":"9","key":"10.1016\/j.imr.2021.100773_bib0025","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/gps.699","article-title":"Development of the Korean version of Alzheimer's disease assessment scale (ADAS-K)","volume":"17","author":"Youn","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"10.1016\/j.imr.2021.100773_bib0026","first-page":"233","article-title":"Development of the Korean stroop test and study of the validity and the reliability","volume":"8","author":"Kim","year":"2004","journal-title":"J Korean Geriatr Soc"},{"issue":"3","key":"10.1016\/j.imr.2021.100773_bib0027","first-page":"126","article-title":"Validation and factor structure of Korean version of the Beck Depression Inventory Second Edition (BDI-II): in a university student sample","volume":"18","author":"Yu","year":"2011","journal-title":"Korean J Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.imr.2021.100773_bib0028","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf"},{"issue":"5","key":"10.1016\/j.imr.2021.100773_bib0029","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1192\/bjp.187.5.450","article-title":"Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial","volume":"187","author":"Onder","year":"2005","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.imr.2021.100773_bib0030","first-page":"29","article-title":"Minimum clinically important differences for the Functioning Assessment Short Test and a battery of neuropsychological tests in bipolar disorders: results from the FACE-BD cohort","author":"Roux","year":"2020","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"16","key":"10.1016\/j.imr.2021.100773_bib0031","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1503\/cmaj.130451","article-title":"Efficacy and safety of cognitive enhancers for patients with mild cognitive impairment: a systematic review and meta-analysis","volume":"185","author":"Tricco","year":"2013","journal-title":"CMAJ"},{"issue":"22","key":"10.1016\/j.imr.2021.100773_bib0032","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/01.wnl.0000303815.69777.26","article-title":"Safety and efficacy of galantamine in subjects with mild cognitive impairment","volume":"70","author":"Winblad","year":"2008","journal-title":"Neurology"},{"issue":"23","key":"10.1016\/j.imr.2021.100773_bib0033","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa050151","article-title":"Vitamin E and donepezil for the treatment of mild cognitive impairment","volume":"352","author":"Petersen","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.imr.2021.100773_bib0034","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1212\/01.WNL.0000134664.80320.92","article-title":"Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial","volume":"63","author":"Salloway","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.imr.2021.100773_bib0035","article-title":"Galantamine for Alzheimer\u2019s disease and mild cognitive impairment","author":"Loy","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"9518","key":"10.1016\/j.imr.2021.100773_bib0036","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0140-6736(06)68542-5","article-title":"Mild cognitive impairment","volume":"367","author":"Gauthier","year":"2006","journal-title":"Lancet North Am Ed"},{"issue":"3","key":"10.1016\/j.imr.2021.100773_bib0037","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archneur.58.3.397","article-title":"Mild cognitive impairment represents early-stage Alzheimer disease","volume":"58","author":"Morris","year":"2001","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.imr.2021.100773_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-017-2040-5","article-title":"Adding Chinese herbal medicine to conventional therapy brings cognitive benefits to patients with Alzheimer\u2019s disease: a retrospective analysis","volume":"17","author":"Shi","year":"2017","journal-title":"BMC Complement Alternat Med"},{"issue":"10","key":"10.1016\/j.imr.2021.100773_bib0039","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/ptr.5679","article-title":"Chinese herbal medicine for mild cognitive impairment: A systematic review and meta-analysis of cognitive outcomes","volume":"30","author":"Dong","year":"2016","journal-title":"Phytother Res"},{"issue":"5","key":"10.1016\/j.imr.2021.100773_bib0040","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1532-5415.2006.00722.x","article-title":"Benefits of combining donepezil plus traditional Japanese herbal medicine on cognition and brain perfusion in Alzheimer's disease: A 12-week observer-blind, donepezil monotherapy controlled trial","volume":"54","author":"Maruyama","year":"2006","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"10.1016\/j.imr.2021.100773_bib0041","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.3390\/molecules181214670","article-title":"Traditional Korean East Asian medicines and herbal formulations for cognitive impairment","volume":"18","author":"Kumar","year":"2013","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.imr.2021.100773_bib0042","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0891988708316855","article-title":"Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment","volume":"21","author":"Lee","year":"2008","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"1","key":"10.1016\/j.imr.2021.100773_bib0043","first-page":"221","article-title":"A Preliminary Study on Standardization of K-MAS (Korean version of Memory Assessment Scales)","volume":"18","author":"CYA","year":"1999","journal-title":"Korean J Clin Psychol"}],"container-title":["Integrative Medicine Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213422021000603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213422021000603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:58:57Z","timestamp":1761987537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213422021000603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2213422021000603"],"URL":"https:\/\/doi.org\/10.1016\/j.imr.2021.100773","relation":{},"ISSN":["2213-4220"],"issn-type":[{"value":"2213-4220","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of dietary supplement (gintonin-enriched fraction from ginseng) in subjective memory impairment: A randomized placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Integrative Medicine Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imr.2021.100773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Korea Institute of Oriental Medicine. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100773"}}